TABLE 4

Analysis of the effects of histamine and mepyramine and determination of the constitutive activity of hH1R, bH1R, rH1R, and gpH1R in the steady-state GTPase assay

Sf9 cell membranes expressing hH1R, bH1R, rH1R, or gpH1R in combination with RGS4 were used to study the constitutive activity. GTPase assays were performed as described under Materials and Methods. The concentration-response curves of the inverse agonist mepyramine (MEP) 18 were determined in a concentration range from 0.1 nM to 10 μM. Data were analyzed by nonlinear regression and were best fit to sigmoidal concentration-response curves. The efficacy of histamine was set 1.00. The ΔHA value refers to the difference of maximal stimulation with 100 μM histamine relative to basal activity. The coefficient ΔHA/Bmax was calculated based on the data given for ΔHA in this table and Bmax values in Table 2. The ΔMEP value refers to the difference of basal activity relative to GTP hydrolysis in presence of 10 μ M MEP. The relative effect of MEP in the last column is the percentage of effect of MEP relative to HA. Data shown are means ± S.E.M. of three experiments performed in duplicates each.




pEC50 (MEP)

ΔHA

ΔHA/Bmax

ΔMEP

Relative effect of MEP
pmol / (mg min) 1 / min pmol / (mg min)
hH1R 8.24 ± 0.26 2.17 ± 0.38 0.37 ± 0.17 0.11 ± 0.01 5.1 ± 0.1
bH1R 7.73 ± 0.01 4.99 ± 0.90 0.48 ± 0.12 0.54 ± 0.08 10.9 ± 1.2
rH1R 7.66 ± 0.06 1.91 ± 0.31 0.33 ± 0.16 0.22 ± 0.01 11.3 ± 0.3
gpH1R
8.96 ± 0.18
1.89 ± 0.26
0.48 ± 0.17
0.26 ± 0.03
13.8 ± 0.9